Particle.news
Download on the App Store

Toyota Pauses Rovanperä’s Super Formula Debut on Medical Advice

Reserve driver Seita Nonaka fills the Motegi seat, with Toyota pledging support for a future comeback.

Overview

  • A medical evaluation led Toyota and Kalle Rovanperä to suspend his 2026 Super Formula program, judging continued competition unsafe.
  • Rovanperä said he will step back from upcoming races to prioritize treatment and recovery after persistent health problems.
  • Reports tie his difficulties to vertigo, including a December BPPV episode that halted testing and recurring symptoms during pre-season running.
  • KCMG will run reserve driver Seita Nonaka at the season opener at Motegi on April 4–5 in Rovanperä’s place.
  • Toyota said it will back his return to circuit racing when he is cleared, noting encouraging progress in winter outings that included a podium in New Zealand.